< Back to scientific publications

Magazine 14.17

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First ItalianζoRk STudy (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2.12

“Hypothesis of COVID-19 Therapy with sildenafil”

Authors: Limodio M. et al.

Date: 2020

Scope of interest: infectivology


Read details
Magazine 12.56

Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.

Authors: Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G.

Date: 2021

Scope of interest: COVID-19 and neurological sequelae


Read details
Magazine 4,213

Diabetes-related quality of life is enhanced by glycaemic improvement in older people

Authors: Abatecola AM, Smoke Scavenger L, Fabbietti P, Testa R, Rabini RA, Bonfigli AR, Corsonello A, Lattanzio F, Paolisso G

Date: 2015

Scope of interest: diabetes


Read details